7 Meme Stocks That Deserve a Fresh Set of Eyes
Meme stocks – you know them as social-media-inspired securities that tend to be speculative. Generally speaking, it’s difficult to suggest otherwise. We’ve seen tons of money poured into failing...
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
| 3.44 | |
| 3.14 | |
| - | |
| 3.45 | |
| 3.08 | |
| 0.7707-35.6 | |
| 43 653 K | |
| 12 876 K | |
| 978 K | |
| -1.61 | |
| 0.411 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Meme stocks – you know them as social-media-inspired securities that tend to be speculative. Generally speaking, it’s difficult to suggest otherwise. We’ve seen tons of money poured into failing...
LOS ANGELES, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce ...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: